Bertrand Vivet, PhD, is a Senior Research Fellow in Medicinal Chemistry in the Drug Discovery group at Novalix. He earned his PhD in biomolecular chemistry from the University of Montpellier, France, in the laboratory of Professor Jean Martinez. He began his industry career in 2000 at Sanofi in France as a medicinal chemist, working on the discovery of small-molecule ligands targeting kinases, ion channels, phosphodiesterases and phosphatases. With over 21 years of experience as team leader and project manager, Bertrand has successfully led projects in oncology, immuno-oncology, rare diseases, diabetes, and infectious diseases, guiding programs from hit identification through to clinical candidate selection. At Novalix, he leads the design of DNA-encoded libraries and oversees affinity-selection data analysis to identify hit compounds.